FDA Quality Assurance Unit
Executive Summary
Center for Drug Evaluation & Research quality assurance head James Bilstad, MD, will retire from the agency effective Dec. 31. Bilstad, previously director of CDER's Office of Drug Evaluation II, moved to the QA unit in April, due to potential conflicts of interest following the appointment of his wife, Cheryl Graham, MD, as VP-U.S. regulatory affairs at Pfizer (1"The Pink Sheet" April 26, p. 4) Bilstad joined the agency in 1974